The company's IPO is currently commanding a grey market premium (GMP) of around Rs 3, or nearly 1% over the upper price band of Rs 590 per share, indicating an estimated listing price of Rs 593. While the GMP is widely tracked as a gauge of investor sentiment, it is an unofficial and unregulated indicator and should not be considered a reliable predictor of listing-day performance.

Once the allotment process is completed, applicants can check whether they have been allotted shares through the registrar, KFin Technologies, or via the BSE and NSE websites. The…

The company's shares are slated to make their stock market debut on August 6. Ahead of the listing, the IPO continues to enjoy strong traction in the grey market, with a Grey…

The company's IPO is currently commanding a grey market premium (GMP) of around Rs 3, or nearly 1% over the upper price band of Rs 590 per share, indicating an estimated listing…

Manipal Health Enterprises debuts at ₹655, 11% above IPO price, amid strong demand and significant investor interest.

Manipal Health Enterprises celebrated a successful market entry on Wednesday, with shares launching at ₹652 on the NSE and ₹655 on the BSE, achieving an eleven percent premium. By…